Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation.
Hopt
U T
UT
Department of Surgery, University of Tübingen, Federal Republic of Germany.
Pfeffer
F
F
Schareck
W
W
Büsing
M
M
Ming
C
C
D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D015774:Ganciclovir / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation; D007970:Leukopenia / Q000139:chemically induced; D016035:Pancreas Transplantation; D013921:Thrombocytopenia / Q000139:chemically induced
D015774:Ganciclovir